What is the future of the transatlantic economic relationship? That was the question Susan Danger, CEO, AmCham EU looked to address in her remarks during the event organised by AmCham Luxembourg, together with Deloitte and the Luxembourg American Chamber of Commerce on Tuesday, 21 June. Cooperation and collaboration were key themes throughout her remarks, underscoring their importance in generating economic growth.
Discussing transatlantic trade and investment in Luxembourg
What is the future of the transatlantic economic relationship? That was the question Susan Danger, CEO, AmCham EU looked to address in her remarks during the event organised by AmCham Luxembourg, together with Deloitte and the Luxembourg American Chamber of Commerce on Tuesday, 21 June. Cooperation and collaboration were key themes throughout her remarks, underscoring their importance in generating economic growth.

She continued by strongly condemning the war in Ukraine and praised the close collaboration between the EU and the US in confronting common challenges. She went on to discuss how AmCham EU, as well as the AmChams in Europe network, supports the EU-US Trade and Technology Council (TTC) as a forum for regulatory and legislative cooperation.
In the spirit of cooperation, AmCham EU and the US Chamber of Commerce, with the support of AmCham Luxembourg and other AmChams, produced the Transatlantic Economy Report 2022. Researched and written independently by Johns Hopkins University researchers, the report confirms what the speakers were highlighting – that the transatlantic relationship is not only resilient, but more important than ever.
The event featured comments from speakers including Daniel S. Hamilton, Senior Fellow, Johns Hopkins University SAIS Foreign Policy Institute (FPI); Casey Mace, Chargé d’Affaires, US Embassy in Luxembourg; John Psaila, CEO, Deloitte Luxembourg; and Paul Schonenberg, Chairman and CEO, AmCham Luxembourg. The tenor of the evening was optimistic, as speakers emphasised the resilience of transatlantic trade and investment in the face of recent crises. In order to push progress forward, however, many of the speakers called on the EU to complete the Single Market, and for the US to remain a reliable, multilaterally minded partner.
Related items
:focal())
Simplifying the Foreign Subsidies Regulation
With the Foreign Subsidies Regulation (FSR) under review, now is the moment to ensure it delivers on its objectives without creating unnecessary complexity. The FSR plays an important role in addressing distortive foreign subsidies. However, its broad scope and resource-intensive procedures risk undermining its effectiveness.
The current framework creates significant burdens for investors and contracting authorities managing public procurement processes. Changes to the Implementing Regulation alone would only provide limited value. Simplification will require targeted amendments to the primary legislation.
Read more about proposed amendments that would help refocus the FSR on high-risk cases and support the EU’s competitiveness goals.
:focal())
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.